EGPA presents with a variety of clinical symptoms include asthma or allergic manifestations associated with marked eosinophilia, as well as organ damage associated with vasculitis, while only about 40% of patients produce the disease-labeled antibody myeloperoxidase (MPO)-ANCA [1]. This evidence concerns the gene MPO and eosinophilic granulomatosis with polyangiitis.